Renflexis
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.renflexis.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Renflexis
RENFLEXIS is a prescription medication designed to treat various autoimmune diseases, including Crohn's disease, psoriatic arthritis, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, and plaque psoriasis. It is intended for children aged 6 years and older as well as adults who have not responded well to other treatments. The medication works to reduce symptoms and maintain remission in moderately to severely active conditions while requiring careful monitoring for serious side effects. Additionally, the Organon Access Program provides support for cost coverage and co-pay assistance for eligible patients.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Renflexis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Renflexis
Website visits: Recent activity has been detected on your website
Click to see if Renflexis had a recent Job posting/layoffs
Earning: See what the market has to say on Renflexis recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Renflexis launches new products
Check out if Renflexis is spiking on competitors!
Check if Renflexis has recently received funding, and reach out quickly before it becomes old news!
Renflexis, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Renflexis has new funding data
Recommended Actions
Reach out to Masked Content who joined Renflexis as Masked Content
Find 3 more new buyers
Compare Similar Companies to Renflexis
Compare insights from companies similar to Renflexis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Renflexis
<$5M
11-50
Private
-
2011
N/A
Company Profile Activity
Activity Insights
Renflexis is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Renflexis is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Renflexis.
Renflexis Tech Stack
A closer look at the technologies used by Renflexis
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Renflexis
Sign Up For FreeTo access detailed company insights
RENFLEXIS is a prescription medication designed to treat various autoimmune diseases, including Crohn's disease, psoriatic arthritis, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, and plaque psoriasis. It is intended for children aged 6 years and older as well as adults who have not responded well to other treatments. The medica... Read More
